Prosensa

Prosensa

Prosensa

We aim to develop innovative, RNA-modulating therapeutics to address unmet medical needs for patients with rare genetic diseases
Founded
2002
Raised
$73.3M
Follow us
Alexa global traffic share
Acquired by
BioMarin Pharmaceutical
24 Nov 2014
$840,000,000
Latest funding Show all
$200,000
Grant - 2014
$29,766,600
Venture capital - 2012

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Prosensa makes some noise.